Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study

End-stage renal disease patients on haemodialysis (HD) have been largely excluded from SARS-CoV-2 vaccine trials due to safety reasons and shown to mount lower responses to vaccination. This study aims to evaluate the immunogenicity and safety of inactivated COVID-19 vaccine among HD patients compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Puspitasari, Metalia, Sattwika, Prenali D., Rahari, Dzerlina S., Wijaya, Wynne, Hidayat, Auliana R. P., Kertia, Nyoman, Purwanto, Bambang, Thobari, Jarir At
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354113/
https://www.ncbi.nlm.nih.gov/pubmed/37463975
http://dx.doi.org/10.1038/s41598-023-38628-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354113/
https://www.ncbi.nlm.nih.gov/pubmed/37463975
http://dx.doi.org/10.1038/s41598-023-38628-2

Ejemplares similares